Literature DB >> 34727210

Trends and variation in benzodiazepine use in nursing homes in the USA.

Ioannis Malagaris1, Hemalkumar B Mehta2, James S Goodwin3.   

Abstract

PURPOSE: Because of toxicities, benzodiazepines are not usually recommended in older adults. We therefore sought to describe the trends in benzodiazepine use in long-term care and examine the variation in benzodiazepine use among nursing homes.
METHODS: In this retrospective repeated cross-sectional analysis of Medicare Parts A, B, and D claims data linked to the Minimum Data Set from 2013 to 2018, we included long-term residents who stayed in a nursing home for at least one entire quarter of a calendar year in 2013-2018. The outcome was whether residents were prescribed a benzodiazepine drug for at least 30 days during each quarter stay. We use mixed effects logistic regression models to assess the variation in benzodiazepine use among nursing homes, adjusting for patient and nursing home characteristics.
RESULTS: The cohort for the time trend analysis included 270,566 unique residents and 1,843,580 quarter stays for 2013-2018. Prescribing rates for short-acting benzodiazepines were stable over 2013-2016, then declined from 12.1% in 2016 to 10.6% in 2018. The rate of long-acting benzodiazepine use remained relatively steady at around 4% over 2013-2018. During 2017-2018, the variation among nursing homes in benzodiazepine use was 7.2% for short-acting vs. 9.3% for long-acting benzodiazepines, after controlling for resident characteristics.
CONCLUSION: Prescribing for short-acting benzodiazepines in long-term care declined after 2016, while long-acting benzodiazepine use did not change. The variation in benzodiazepine use among nursing homes is substantial. Identifying factors that explain this variation may help in developing strategies for deprescribing benzodiazepines in nursing home residents.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Benzodiazepine; Long-term care; Medicare; Nursing home

Mesh:

Substances:

Year:  2021        PMID: 34727210      PMCID: PMC9138049          DOI: 10.1007/s00228-021-03244-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   3.064


  21 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

Review 2.  Explicit criteria for determining potentially inappropriate medication use by the elderly. An update.

Authors:  M H Beers
Journal:  Arch Intern Med       Date:  1997-07-28

3.  National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Authors:  Donovan T Maust; Frederic C Blow; Ilse R Wiechers; Helen C Kales; Steven C Marcus
Journal:  J Clin Psychiatry       Date:  2017-04       Impact factor: 4.384

Review 4.  A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.

Authors:  Cara Tannenbaum; Amélie Paquette; Sarah Hilmer; Jayna Holroyd-Leduc; Ryan Carnahan
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

5.  Benzodiazepines of long and short elimination half-life and the risk of hip fracture.

Authors:  W A Ray; M R Griffin; W Downey
Journal:  JAMA       Date:  1989-12-15       Impact factor: 56.272

6.  Trends in Utilization of Prescribed Controlled Substances in US Commercially Insured Adults, 2004-2019.

Authors:  Katsiaryna Bykov; Mengdong He; Joshua J Gagne
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

7.  Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture.

Authors:  P S Wang; R L Bohn; R J Glynn; H Mogun; J Avorn
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

Review 8.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.

Authors:  John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra
Journal:  Arch Intern Med       Date:  2009-11-23

9.  Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?

Authors:  Anita K Wagner; Fang Zhang; Stephen B Soumerai; Alexander M Walker; Jerry H Gurwitz; Robert J Glynn; Dennis Ross-Degnan
Journal:  Arch Intern Med       Date:  2004-07-26

10.  The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors.

Authors:  Hua Chen; Afam Nwangwu; Rajender Aparasu; Ekere Essien; Shawn Sun; Kwan Lee
Journal:  Psychiatr Serv       Date:  2008-10       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.